GLS2 and cancer: The use of L-glutaminase-dependent deprivation treatment, which hydrolyzes L-glutamine into glutamate and ammonia and specifically suppresses tumor development by preventing the synthesis of new proteins, also raises levels of oxidative stress superoxides and encourages cancer cells’ demise [31].